Q2 2024 |
75 |
$336M |
+$11M |
-$25.9M |
-$14.9M |
GLD, LIN, CMPO, IVAC, BC
|
13F-HR |
8/13/2024, 12:56 PM |
Q1 2024 |
80 |
$401M |
+$8.37M |
-$66.9M |
-$58.5M |
GLD, LIN, BC, INVE, FNA
|
13F-HR |
5/14/2024, 02:25 PM |
Q4 2023 |
77 |
$450M |
+$26M |
-$18.2M |
+$7.73M |
BC, GLD, LIN, INVE, FNA
|
13F-HR |
2/12/2024, 11:12 AM |
Q3 2023 |
74 |
$406M |
+$5.56M |
-$40M |
-$34.4M |
GLD, BC, LIN, INVE, FNA
|
13F-HR |
11/9/2023, 05:04 PM |
Q2 2023 |
83 |
$493M |
+$52.4M |
-$36M |
+$16.4M |
GLD, BC, LIN, FNA, INVE
|
13F-HR |
8/11/2023, 05:54 PM |
Q1 2023 |
80 |
$469M |
+$49.1M |
-$72.9M |
-$23.8M |
GLD, BC, LIN, IVAC, PROK
|
13F-HR |
5/12/2023, 12:30 PM |
Q4 2022 |
86 |
$460M |
+$16.5M |
-$27.9M |
-$11.4M |
GLD, BC, LINXXXX, IVAC, CTIC
|
13F-HR |
2/13/2023, 05:43 PM |
Q3 2022 |
92 |
$479M |
+$22M |
-$13.5M |
+$8.44M |
GLD, BC, LINXXXX, INVE, IVAC
|
13F-HR |
11/14/2022, 04:34 PM |
Q2 2022 |
95 |
$484M |
+$42.2M |
-$46M |
-$3.79M |
GLD, BC, LINXXXX, INVE, IVAC
|
13F-HR |
8/10/2022, 12:06 PM |
Q1 2022 |
111 |
$563M |
+$66.8M |
-$54.5M |
+$12.2M |
GLD, LINXXXX, BC, INVE, IVAC
|
Restatement |
7/27/2022, 11:21 AM |
Q4 2021 |
101 |
$639M |
+$48.4M |
-$51.4M |
-$3M |
GLD, LINXXXX, INVE, BC, RPRX
|
13F-HR |
2/10/2022, 05:03 PM |
Q3 2021 |
96 |
$613M |
+$99.1M |
-$105M |
-$6.17M |
GLD, LINXXXX, BC, INVE, RPRX
|
13F-HR |
11/15/2021, 04:15 PM |
Q2 2021 |
91 |
$662M |
+$57.9M |
-$23.4M |
+$34.5M |
GLD, LINXXXX, BC, DRRX, INVE
|
13F-HR |
8/16/2021, 12:14 PM |
Q1 2021 |
81 |
$592M |
$0 |
$0 |
|
GLD, LINXXXX, DRRX, BC, IVAC
|
New Holdings |
6/3/2021, 09:31 AM |
Q1 2021 |
81 |
$592M |
+$59.2M |
-$12M |
+$47.2M |
GLD, LINXXXX, DRRX, BC, IVAC
|
13F-HR |
5/17/2021, 09:57 AM |
Q4 2020 |
72 |
$514M |
+$26.4M |
-$158M |
-$131M |
GLD, DRRX, LINXXXX, BC, IVAC
|
13F-HR |
2/10/2021, 02:20 PM |
Q3 2020 |
74 |
$559M |
+$17.4M |
-$23.4M |
-$5.98M |
GLD, RPRX, LINXXXX, DRRX, DCP
|
13F-HR |
11/12/2020, 11:05 AM |
Q2 2020 |
73 |
$565M |
+$83.4M |
-$18.4M |
+$65M |
GLD, DRRX, RPRX, LINXXXX, DCP
|
13F-HR |
8/12/2020, 09:39 AM |
Q1 2020 |
56 |
$383M |
+$78.9M |
-$79.6M |
-$747K |
GLD, DRRX, LINXXXX, XRX, IVAC
|
Restatement |
5/14/2020, 02:21 PM |
Q4 2019 |
44 |
$632M |
$0 |
$0 |
|
DRRX, GLD, DCP, XRX, ARQL
|
13F-HR |
2/14/2020, 11:22 AM |